Johnson & Johnson to Begin Coronavirus Vaccine Clinical Trial in July

    0
    278
    Johnson & Johnson to Begin Coronavirus Vaccine Clinical Trial in July

    Johnson & Johnson(NYSE:JNJ) announced on Wednesday that it expects to begin a phase 1/2a clinical trial of its COVID-19 vaccine candidate Ad26.COV2-S, recombinant, in the second half of July. The…
    Read More

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here